Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Employees Cystic Fibrosis Foundation Jack Mahler, M.D.

Jack Mahler, M.D.

Key employee

Chief Investment Officer at Cystic Fibrosis Foundation

Fiscal year ended December 31, 2022. Published on January 25, 2026.

$2,694,782
2022

Total compensation

Jack Mahler, M.D. has been listed as an employee of Cystic Fibrosis Foundation in Form 990 filings since fiscal year 2017. Total compensation for Jack Mahler, M.D. has increased by 99.7% from 2017 to 2022.

Annual compensation details

$2,694,782
+30.9%
Chief Investment Officer
2022
$2.5M
40 hrs/wk
$231k
--
$2,058,545
+8.4%
Chief Investment Officer
2021
$1.4M
40 hrs/wk
$658k
--
$1,898,720
+19.9%
Chief Investment Officer
2020
$1.3M
40 hrs/wk
$637k
--
$1,583,838
+46.9%
Chief Investment Officer
2019
$1.1M
40 hrs/wk
$455k
--
$1,078,107
-20.1%
Chief Investment Officer
2018
$925k
40 hrs/wk
$154k
--
$1,349,390
Chief Investment Officer
2017
$1.2M
55 hrs/wk
$153k
--

Total compensation by year

Compare the compensation of Jack Mahler, M.D. to:

Revisions to this profile

January 25, 2026:
2022 Cystic Fibrosis Foundation 990 published
January 25, 2026:
2021 Cystic Fibrosis Foundation 990 published
January 24, 2026:
2020 Cystic Fibrosis Foundation 990 published

Get an email update when compensation for Jack Mahler, M.D. is updated

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →
2022

Other employees at Cystic Fibrosis Foundation

Michael P Boyle, M.D.
President and Chief Executive Officer
$1,349,782
$950,256 No related comp$399,526
Earl Lee
Managing Director, Investments
$1,257,375
$1,023,013 No related comp$234,362
Eric Koehrsen
Managing Director, Investments
$1,169,271
$921,034 No related comp$248,237
Bruce Marshall, M.D.
Executive Vice President and Chief Medical Officer
$796,918
$692,205 No related comp$104,713
John P Clancy, M.D.
Senior Vice President, Clinical Research
$705,948
$551,336 No related comp$154,612
Mary Dwight
Chief Policy and Advocacy Officer
$672,921
$543,012 No related comp$129,909
Marybeth McMahon
Chief of Staff
$645,343
$552,564 No related comp$92,779
Anthony Durmowicz, M.D.
Vice President, Clinical Development
$638,695
$574,023 No related comp$64,672
Irena Barisic
Executive Vice President, CFAO, ASST SEC and ASST TRSR
$629,321
$557,940 No related comp$71,381